APA (7th ed.) Citation

Ma, X., Liu, S., Dong, X., Li, X., Wang, F., Zhang, J., . . . Xu, L. (2025). Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy. Pharmaceuticals (14248247), 18(12), 1867. https://doi.org/10.3390/ph18121867

Chicago Style (17th ed.) Citation

Ma, Xueling, et al. "Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy." Pharmaceuticals (14248247) 18, no. 12 (2025): 1867. https://doi.org/10.3390/ph18121867.

MLA (9th ed.) Citation

Ma, Xueling, et al. "Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy." Pharmaceuticals (14248247), vol. 18, no. 12, 2025, p. 1867, https://doi.org/10.3390/ph18121867.